NEWS
10 APR 2013 Trading Update
ABI is pleased to announce that it has today received a second order from Chubeworkx Guernsey Ltd (“Chubeworkx”) for 1.4 million CHUBE‐branded, disposable breath alcohol detectors taking Chubeworkx’s orders to date to 4.9 million. In addition, and as previously announced, Chubeworx has also paid a licensing fee of $1.0m (the majority of which will be accounted for in the current year), bringing the total revenue with Chubeworkx, and its associated marketing company en10 Limited, to over $2m for 2013.
19 FEB 2013 Update on French Certification for Breathalysers & Product Launch; Trading Update
ABI is pleased to announce that its proprietary disposable breath alcohol detectors will be formally launched to the French market this afternoon by ABI’s partners Chubeworkx Guernsey Ltd and (en)10 (Global) Ltd. The national reference laboratory of France, Laboratoire National de Métrologie et d'Essais (“LNE”), has recommended that the Company’s breath alcohol detector is in compliance with the quality criteria defined in French Standard NF X 20-702 for disposable breathalysers and the final award of the NF Marque (“NF Mark”) from the Comité de Marque is expected this week. In addition, the Company is also pleased to report that sales of its test for heparin-induced thrombocytopenia ("HIT"), PIFA Heparin/PF4, have continued to grow strongly with revenues for the first six weeks of 2013 exceeding those for the whole of the first quarter of 2012.
11 DEC 2012 3.5m unit Order for Breath Alcohol Tubes; Part Receipt of Licence Fee
The Company is pleased to announce that it has received a purchase order to manufacture 3.5 million units of a custom breath alcohol detector, based on the Company’s BreathScan product, for $1.05 million. The order will support the entrance of Sono International, Ltd. (“SONO”), a London-based multinational corporation, into the French disposable breath alcohol detector marketplace.
10 DEC 2012 Notice of Annual General Meeting
ABI is pleased to announce that a notice of the Company’s Annual General Meeting, to be held at 11h00 EST on 20 December 2012 at RiverWinds in Thorofare New Jersey 08086, USA, has been posted to shareholders. All shareholders are welcome to attend in person or issue a proxy to vote on the resolutions at the Meeting.
26 NOV 2012 Distribution Partnership Forged in China
The Company is pleased to announce the signing of a distribution agreement with Novotek Therapeutics Inc., a Beijing‐based pharmaceutical and in vitro diagnostic business development corporation, for ABI’s innovative Particle ImmunoFiltration Assay ("PIFA") products. The multi‐year agreement assigns exclusive sales and marketing rights for the products to Novotek in Mainland China.
17 SEP 2012 $675,000 Private Placing
ABI is pleased to announce the investment of US entrepreneur and politian,Thomas J. Knox through the purchase of 30M common shares and 10M preferred shares. Knox is the Chief Executive Officer of Knox Consulting Group and Indecs Corp.
All Products Proudly Manufactured in the USA
Government & Defense Procurement Information
For additional information, please call +1 856 848 2116 or 1.800.451.TEST.
|
